Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: A meta analysis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 18, 2014, Pages 1839-1844

  Zhu, Yu Juan ^a   Zheng, Ying Ru ^a   Li, Li ^a   Zhou, Hao ^a   Liao, Xi ^a   Guo, Jian Xin ^a   Yi, Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fetal RhD; Maternal blood; Prenatal diagnosis

Indexed keywords

CELL FREE FETAL DNA; DNA; UNCLASSIFIED DRUG; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIGEN;

ARTICLE; BLOOD GROUP RHESUS SYSTEM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FETAL RHD GENOTYPING; FETUS; FIRST TRIMESTER PREGNANCY; GENOTYPING TECHNIQUE; GESTATIONAL AGE; HUMAN; MATERNAL BLOOD; META ANALYSIS; NON INVASIVE MEASUREMENT; RECEIVER OPERATING CHARACTERISTIC; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; THIRD TRIMESTER PREGNANCY; VALIDITY; BLOOD; CELL FREE SYSTEM; ERYTHROBLASTOSIS, FETAL; GENETICS; METABOLISM; NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; REPRODUCIBILITY;

CELL-FREE SYSTEM; DNA; ERYTHROBLASTOSIS, FETAL; FEMALE; FETUS; GENOTYPING TECHNIQUES; HUMANS; INFANT, NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 84900437826     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.882306     Document Type: Article

References (28)

1. Chen JC, Lin TM, Chen YL, et al. RHD 1227A is an important genetic marker for RhD(el) individuals. Am J Clin Pathol 2004; 122:193-8.
2. Avent ND. RHD genotyping from maternal plasma: guidelines and technical challenges. Methods Mol Biol 2008;444:185-201.
3. Daniels G. The molecular genetics of blood group polymorphism. Transpl Immunol 2005;14:143-53.
4. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
5. Farina A, Leshane ES, Romero R, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005;193:421-5.
6. Galbiati S, Smid M, Gambini D, et al. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005;117: 243-8.
7. Li Y, Holzgreve W, Din E, et al. Cell-free DNA in maternal plasma: is it all a question of size? Ann N Y Acad Sci 2006;1075:81-7.
8. Liu FM, Wang XY, Feng X, et al. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis. Acta Obstet Gynecol Scand 2007;86:535-41.
9. Puszyk WM, Crea F, Old RW. Noninvasive prenatal diagnosis of aneuploidy using cell-free nucleic acids in maternal blood: promises and unanswered questions. Prenat Diagn 2008;28:1-6.
10. Guo QW, Zhou YL. Noninvasive prenatal diagnosis of single gene disorders through cell-free fetal DNA in maternal blood. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009;26:410-13.
11. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol 2006;195:1163-73.
12. Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK. Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 2003; 85:300-6.
13. Scheffer PG, Van Der Schoot CE, Page-Christiaens GC, De Haas M. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 2011;118:1340-8.
14. Clausen FB, Jakobsen TR, Rieneck K, et al. Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD. PLoS One 2013;8:e76990.
15. Macher HC, Noguerol P, Medrano-Campillo P, et al. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Clin Chim Acta 2011;413:490-4.
16. Bombard AT, Akolekar R, Farkas DH, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn 2011;31: 802-8.
17. Tynan JA, Angkachatchai V, Ehrich M, et al. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol 2011;204:251 e1-6.
18. Atamaniuk J, Stuhlmeier KM, Karimi A, Mueller MM. Comparison of PCR methods for detecting fetal RhDin maternal plasma. J Clin Lab Anal 2009;23:24-8.
19. Clausen FB, Krog GR, Rieneck K, et al. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn 2005;25:1040-4.
20. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
21. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000;95:3662-8.
22. Gautier E, Benachi A, Giovangrandi Y, et al. RhD genotyping by maternal serum analysis: a two-year experience. Am J Obstet Gynecol 2005;192:666-9.
23. Legler TJ, Lynen R, Maas JH, et al. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction. Transfus Apher Sci 2002;27:217-23.
24. Costa JM, Giovangrandi Y, Ernault P, et al. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255-60.
25. Chim SS, Tong YK, Chiu RW, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005;102:14753-8.
26. Chiu RW, Chim SS, Wong IH, et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007; 170:941-50.
27. Chiu RW, Lo YM. Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011;16:88-93.
28. Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52: 2211-18.